JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NBIS
2876
PUT
Nebius Group N.V.
NBIS
$66B
| $3.27M | ﹤0.01% |
+100,000
| New | +$3.26M |
2017 Q4
0 quarters
|
|
|
PF
2877
CALL
DELISTED
Pinnacle Foods, Inc.
PF
| $3.27M | ﹤0.01% |
+55,000
| New | +$3.1M |
2017 Q4
0 quarters
|
|
|
ZIXI
2878
DELISTED
Zix Corporation
ZIXI
| $3.27M | ﹤0.01% |
745,255
-5,127
| -0.7% | -$24.1K |
2015 Q3
9 quarters
|
|
2879
CALL
Yum! Brands
YUM
$37.1B
| $3.26M | ﹤0.01% |
40,000
+25,000
| +167% | +$1.98M |
2016 Q2
6 quarters
|
|
|
IMMU
2880
CALL
DELISTED
Immunomedics Inc
IMMU
| $3.26M | ﹤0.01% |
201,700
| – | – |
2016 Q4
4 quarters
|
|
2881
Century Communities
CCS
$1.7B
| $3.25M | ﹤0.01% |
104,631
+103,100
| +6,734% | +$2.94M |
2016 Q4
4 quarters
|
|
2882
Lloyds Banking Group
LYG
$79.1B
| $3.24M | ﹤0.01% |
864,612
-1,315,241
| -60% | -$4.74M |
2013 Q2
18 quarters
|
|
|
PGTI
2883
DELISTED
PGT, Inc.
PGTI
| $3.23M | ﹤0.01% |
191,925
+121,419
| +172% | +$1.86M |
2016 Q1
7 quarters
|
|
|
MIK
2884
DELISTED
Michaels Stores, Inc
MIK
| $3.22M | ﹤0.01% |
133,242
-136,533
| -51% | -$2.82M |
2015 Q1
11 quarters
|
|
|
JUNO
2885
DELISTED
Juno Therapeutics, Inc.
JUNO
| $3.21M | ﹤0.01% |
70,286
-14,888
| -17% | -$743K |
2014 Q4
12 quarters
|
|
|
RRTS
2886
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $3.21M | ﹤0.01% |
16,647
+46
| +0.3% | +$9.8K |
2015 Q4
8 quarters
|
|
2887
Invesco Dorsey Wright Momentum ETF
PDP
$1.5B
| $3.2M | ﹤0.01% |
62,063
-10,858
| -15% | -$551K |
2013 Q2
18 quarters
|
|
|
SYRS
2888
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $3.2M | ﹤0.01% |
32,880
+20,227
| +160% | +$2.72M |
2016 Q3
5 quarters
|
|
2889
PennantPark Floating Rate Capital
PFLT
$679M
| $3.2M | ﹤0.01% |
232,973
+89,091
| +62% | +$1.26M |
2013 Q2
18 quarters
|
|
2890
Cato Corp
CATO
$47.8M
| $3.19M | ﹤0.01% |
200,662
-162,519
| -45% | -$2.36M |
2013 Q2
18 quarters
|
|
|
GG.WS.A
2891
PUT
DELISTED
GOLDCORP INC SERIES A WARRANTS EXP 5/30/2007
GG.WS.A
| $3.19M | ﹤0.01% |
250,000
-250,000
| -50% | -$3.19M |
2017 Q3
1 quarter
|
|
2892
Strategic Education
STRA
$1.77B
| $3.19M | ﹤0.01% |
35,594
+16,707
| +88% | +$1.54M |
2013 Q2
18 quarters
|
|
2893
Corcept Therapeutics
CORT
$12.6B
| $3.18M | ﹤0.01% |
176,182
+172,046
| +4,160% | +$3.12M |
2016 Q4
4 quarters
|
|
2894
PUT
Tapestry
TPR
$23.6B
| $3.18M | ﹤0.01% |
71,900
+4,600
| +7% | +$190K |
2017 Q3
1 quarter
|
|
2895
Waterstone Financial
WSBF
$358M
| $3.18M | ﹤0.01% |
186,485
+7,814
| +4% | +$147K |
2015 Q3
9 quarters
|
|
|
NP
2896
DELISTED
Neenah, Inc. Common Stock
NP
| $3.17M | ﹤0.01% |
34,931
+26,436
| +311% | +$2.32M |
2013 Q2
18 quarters
|
|
2897
Lindsay Corp
LNN
$1.16B
| $3.16M | ﹤0.01% |
35,789
+13,855
| +63% | +$1.26M |
2013 Q2
18 quarters
|
|
|
KSU
2898
CALL
DELISTED
Kansas City Southern
KSU
| $3.16M | ﹤0.01% |
+30,000
| New | +$3.2M |
2017 Q4
0 quarters
|
|
2899
Builders FirstSource
BLDR
$6.05B
| $3.15M | ﹤0.01% |
144,719
+143,212
| +9,503% | +$2.72M |
2017 Q1
3 quarters
|
|
2900
CALL
HDFC Bank
HDB
$115B
| $3.15M | ﹤0.01% |
+124,000
| New | +$2.97M |
2017 Q4
0 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.